Northern Edge Wins Cross-Border Deal of the Year
We are delighted to announce that the Northern Edge-advised Sale of RadMD, LLC to Medica PLC was named the winner in the Cross-Border Deal of the Year ($10 to $25 million) category at the 20th Annual M&A Advisor Awards. This is the 6th consecutive year that Northern Edge has won an award.
“The award recipients represent the finest in the M&A industry this past year and earned these honors by standing out in a group of extremely impressive finalists,” said Roger Aguinaldo, Founder of The M&A Advisor. “From lower middle market to multi-billion dollar deals, we are recognizing the leading transactions, firms and individuals that represent the highest levels of achievement.”
Bob Goldsmith, President, CEO and Founding Partner of Northern Edge Advisors LLC, attended the ceremony at The New York Athletic Club on Wednesday, November 17th and commented: “It is rewarding to , because our firm has built its reputation on its unique expertise in complex sell-side transactions and unparalleled knowledge of international markets. This award helps cap a remarkably prolific year at Northern Edge and reflects the efforts our team members make every day to deliver exceptional outcomes for our clients in helping them achieve their financial goals.”
RadMD, LLC is a leading Imaging Contract Research Organization providing services to the fast-growing clinical trials market and focusing on providing high-value imaging expertise services and applying cutting edge technology to reduce costs and improve efficiency in drug and device development.
Headquartered in the UK and Ireland, Medica Group PLC provides teleradiology services, outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound and plain film (x-ray) images. In addition, Medica offers retinal diagnostic screenings in Ireland and selective managed services in diagnostics to the public and private sectors. The acquisition of RadMD supports Medica Group PLC’s strategy of diversification of customer base, geographical operations, and an entry into the exciting Clinical Trials market.
This year, Northern Edge was also recognized as a finalist for several other categories and is a past winner of these prestigious accolades. Previous Northern Edge awards include:
- M&A Deal of the Year (25 – 50 million) at the 18th Annual M&A Advisor Awards in 2019
- Private Equity Deal of the Year (10 – 50 million) at the 17th Annual M&A Advisor Awards in 2018
- Healthcare & Life Sciences Deal of the Year (Over $100M) at the 15th Annual M&A Advisor Awards in 2016
The 20th Annual M&A Advisor Awards Gala honored the professionals whose activities set the standard for M&A transactions. This year, over 200 nominees, representing over 500 companies, became finalists for the awards.